Revenue
2021
2022
2023
2024
2025
Euroapi (EAPI)
Price€0.7470Cached quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €848.2M | €911.9M | €1.01B | €976.6M | €892.8M |
| Gross profit | €144.8M | €142.4M | €164.6M | €176.9M | €109.1M |
| Gross margin | 17.07% | 15.62% | 16.25% | 18.11% | 12.22% |
| Research & development | €27.3M | €25.8M | €29.6M | €21.8M | €17.0M |
| Operating expenses | €275.4M | €262.8M | €398.9M | €177.7M | €121.9M |
| Operating income | −€130.6M | −€120.4M | −€234.3M | −€800,000 | −€12.8M |
| Operating margin | −15.40% | −13.20% | −23.12% | −0.08% | −1.43% |
| EBITDA | €10.0M | −€42.5M | €70.7M | €101.8M | N/A |
| EBITDA margin | 1.18% | −4.66% | 6.98% | 10.42% | N/A |
| Net income | −€211.2M | −€130.6M | −€189.7M | −€15.0M | −€8.1M |
| Net profit margin | −24.90% | −14.32% | −18.72% | −1.54% | −0.91% |
| Basic EPSper basic share | -€2.23 | -€1.38 | -€2.02 | -€0.16 | -€0.18 |
| Diluted EPSper diluted share | -€2.23 | -€1.38 | -€2.02 | -€0.16 | -€0.18 |
Owners
Reported shareholders and owner groups
29.60%of company shares
Sanofi-Aventis ParticipationsSource updated Aug 7, 2026
View holders
| Holder | Ownership |
|---|---|
| 29.60%Aug 7, 2026 | |
| 11.80%Aug 7, 2026 | |
| 5.37%Aug 7, 2026 | |
| 5.13%Aug 7, 2026 |
These Euronext company-profile figures report shares in the company's capital. Named holders and owner groups are shown as published; free float, treasury shares, and unspecified holders are excluded from the colored segments.
Gray completes the 100% scale; it is not an estimate of other owners.
Source: Euronext / Cofisem ↗Checked Oct 21, 2026